Related Experiment Video
Updated: May 8, 2026
05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
Probiotic therapy-part 2: clinical perspectives
1St.Louis, Missouri.
International Journal of Pharmaceutical Compounding
|August 27, 2013
Summary
This review discusses probiotic therapy effectiveness and safety, emphasizing data review for supplement selection. Pharmacists can offer tailored probiotic formulations and novel dosage forms.
Area of Science:
- Microbiology
- Pharmacology
- Gastroenterology
Background:
- Probiotic therapy benefits are increasingly documented, yet mechanisms of action remain unclear.
- Evidence for probiotic efficacy is growing through case reports, studies, and clinical trials.
- Careful review of published data is crucial for selecting effective and safe probiotic supplements.
Purpose of the Study:
- To discuss the efficacy and safety of probiotic treatments.
- To highlight the role of pediatric gastroenterologists and compounding pharmacists in tailoring probiotic regimens.
- To explore the potential of innovative compounding and future developments in probiotic formulations.
Main Methods:
- Review of published data on probiotic efficacy and safety.
- Discussion by experts including a pediatric gastroenterologist and a compounding pharmacist.
- Analysis of case reports, research studies, and randomized controlled trials.
Main Results:
- Probiotic therapy benefits are increasingly supported by scientific literature.
- Compounding pharmacists can provide novel probiotic dosage forms.
- Future probiotic therapies may involve genetically engineered strains for targeted effects.
Conclusions:
- Selecting probiotic supplements requires careful consideration of available scientific data.
- Pharmacists play a key role in providing information and customized probiotic formulations.
- Advancements in probiotic formulations and genetically engineered strains show promise for future gut health interventions.
Related Concept Videos
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...